The Western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trial
- 1 December 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (19), 1298-1303
- https://doi.org/10.1016/0002-9149(90)91157-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- Ventricular function and infarct size: The Western Washington Intravenous Streptokinase in Myocardial Infarction TrialJournal of the American College of Cardiology, 1988
- Recent changes in management of acute myocardial infarction: Implications for emergency care physiciansJournal of the American College of Cardiology, 1988
- The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.Circulation, 1988
- Update from the thrombolysis in myocardial infarction trialJournal of the American College of Cardiology, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986